New Corona virus disease 2019. new Corona virus disease 2019
Conditions
Interventions
Intervention 1: Intervention group: Treatment protocol approved by the Ministry of Health during the period of hospitalization + herbal supplement taking from a combination of black myrobalan and mast
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients admitted with a diagnosis of COVID-19 COVID-19 patients who are willing to participate in study The patient should not be among high-risk groups, such as breastfeeding or pregnant or etc. Age> 18 years old The patient does not have a specific underlying disease Study
Exclusion criteria
Exclusion criteria: People who are under 18 years of age People who are among the high-risk group People who have a specific underlying disease People who are characterized as severe in the illness course
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of disease. Timepoint: During the hospital stay, on a daily basis. Method of measurement: The severity of patient's clinical symptoms is measured on the basis of visual analog scale.;Vital Signs. Timepoint: During the hospital stay, on a daily basis. Method of measurement: Vital signs monitoring device.;C-Reactive Protein. Timepoint: During the hospital stay, on a daily basis. Method of measurement: C-Reactive Protein test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary damages after illness. Timepoint: At the beginning of the study and 14 and 30 days after taking herbal supplements. Method of measurement: Chest Computed Tomography Scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Hashemi shiri
Jahrom University of Medical Sciences
Outcome results
None listed